# Removal of Beta Blocker Drugs by Hemodialysis

> **NCT03361280** · PHASE1,PHASE2 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 8 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** Beta blocker

## Key facts

- **NCT ID:** NCT03361280
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-27
- **Primary completion:** 2016-03-10
- **Final completion:** 2016-03-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03361280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03361280, "Removal of Beta Blocker Drugs by Hemodialysis". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03361280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*